CYTK vs. SCHG
Compare and contrast key facts about Cytokinetics, Incorporated (CYTK) and Schwab U.S. Large-Cap Growth ETF (SCHG).
SCHG is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Large-Cap Growth Total Stock Market Total Return Index. It was launched on Dec 11, 2009.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CYTK or SCHG.
Correlation
The correlation between CYTK and SCHG is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CYTK vs. SCHG - Performance Comparison
Key characteristics
CYTK:
-0.88
SCHG:
0.22
CYTK:
-1.21
SCHG:
0.48
CYTK:
0.85
SCHG:
1.07
CYTK:
-0.63
SCHG:
0.23
CYTK:
-1.68
SCHG:
0.88
CYTK:
25.39%
SCHG:
6.18%
CYTK:
48.86%
SCHG:
24.57%
CYTK:
-97.09%
SCHG:
-34.59%
CYTK:
-63.46%
SCHG:
-18.51%
Returns By Period
In the year-to-date period, CYTK achieves a -16.07% return, which is significantly lower than SCHG's -14.91% return. Over the past 10 years, CYTK has outperformed SCHG with an annualized return of 18.31%, while SCHG has yielded a comparatively lower 14.20% annualized return.
CYTK
-16.07%
-9.14%
-28.18%
-41.07%
21.04%
18.31%
SCHG
-14.91%
-7.40%
-10.61%
6.90%
16.81%
14.20%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CYTK vs. SCHG — Risk-Adjusted Performance Rank
CYTK
SCHG
CYTK vs. SCHG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Cytokinetics, Incorporated (CYTK) and Schwab U.S. Large-Cap Growth ETF (SCHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CYTK vs. SCHG - Dividend Comparison
CYTK has not paid dividends to shareholders, while SCHG's dividend yield for the trailing twelve months is around 0.48%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CYTK Cytokinetics, Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHG Schwab U.S. Large-Cap Growth ETF | 0.48% | 0.40% | 0.46% | 0.55% | 0.42% | 0.52% | 0.82% | 1.27% | 1.01% | 1.04% | 1.22% | 1.09% |
Drawdowns
CYTK vs. SCHG - Drawdown Comparison
The maximum CYTK drawdown since its inception was -97.09%, which is greater than SCHG's maximum drawdown of -34.59%. Use the drawdown chart below to compare losses from any high point for CYTK and SCHG. For additional features, visit the drawdowns tool.
Volatility
CYTK vs. SCHG - Volatility Comparison
Cytokinetics, Incorporated (CYTK) has a higher volatility of 20.23% compared to Schwab U.S. Large-Cap Growth ETF (SCHG) at 15.88%. This indicates that CYTK's price experiences larger fluctuations and is considered to be riskier than SCHG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.